PATENT CLAIM ANALYSIS

Application Number: 15975854
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["548", "469000"]

Abstract:
The present application, among other things, provides compounds that are capable of inhibiting the activity of anti-apoptotic Bcl-2 family proteins, for example, myeloid cell leukemia-1 (Mcl-1) protein. The present invention also provides pharmaceutical compositions as well as methods for using provided compounds for treatment of diseases and conditions (e.g., cancer) characterized by the over-expression or dysregulation of Mcl-1 protein. In some embodiments, a provided compound has the structure of formula I. In some embodiments, a provided compound has the structure of formula II.

Claim (Index 20):
The compound of  claim 1 , wherein the compound is selected from Table 1, or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 93.0
- Lexical Diversity: 1.63333
- Patent Class: 548.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14914307', '14885181', '15129042', '14429799', '14966821']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7848752041406569
- 35 USC 102 Novelty (BERT): 0.5805758352877594
- Combined Prediction Score: 0.7644452672553672
- Mean Citation Score: 388.026742
- Max Citation Score: 480.23093
- Similarity Product: 441.7448823649013

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test